Summary
In a previous study we have shown that transplacental transfer of hepatitis A antibodies to preterm infants does not differ from that observed in full-term infants. This follow-up study was designed to investigate the decline of hepatitis A virus (HAV) antibodies during the first 7 months of life in full-term and preterm infants, in an endemic region for hepatitis A. Two hundred and fifty newborn infants— 147 full-term and 103 preterm infants—were enrolled. Blood samples from the infants were taken at birth, and at 3 and 7 months of age. Anti-HAV titers were determined by ELISA. A concentration of ≥1∶20 mlU/ml was considered protective. Protective hepatitis A antibodies were present at birth in 48.3% of all full-term and 49.5% of all premature infants. By the age of 7 months only 13% of full-term and 21.7% of preterm infants still had protective titers. For the seropositive full-term infants the geometric mean titers (GMT) were 15,698, 6,107 and 345 at birth, 3 months and 7 months, respectively, and for preterm infants, 10,378, 2,307 and 225 at birth, 3 months and 7 months, respectively. Significant differences in GMT between preterm and full-term infants were found at birth and at 3 monts of age (P<0.05). In a region endemic for hepatitis A, low levels of anti-HAV at 7 months of age may justify trials on infant vaccination since this is the most effective way to eliminate hepatitis A from circulation.
References
Green, M. S., Block, C., Saltier, P. E.: Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. Rev. Infect. Dis. 2 (1989) 464–469.
Kark, J. D., Bar Shani, S.: Hepatitis A antibody in Israel Defense Forces recruits. J. Med. Virol. 6 (1981) 341–345.
Karetnyi, Y. V., Mendelson, E., Shlyakhov, E., Rubinstein, E., Golubev, N., Levin, R., Sandler, M., Schreiber, M., Rubinstein, V., Shif, I., Handsher, R., Varsano, N., Modan, B.: Prevalence of antibodies against hepatitis A virus among new immigrants in Israel. J. Med. Virol. 46 (1995) 61–65.
Linder, N., Karetnyi, Y., Kuint, J., Mendelson, E., Dagan, R.: Symptomatic hepatitis A virus infection during the first year of life. Pediatr. Infect. Dis. J. 14 (1995) 628–629.
Evans, H. E., Akpata, S. O., Glass, C.: Serum immunoglobulin levels in premature and full term infants. Am. J. Clin. Pathol. 56 (1971) 416–418.
Louis, L., Patrick, B., Beat, A., Reinhard, G.: Inactivated virosome hepatitis A vaccine. Lancet 343 (1994) 322–325.
Green, M. S., Cohen, D., Lerman, Y., Sjogren, M., Binn, L. N., Zur, S., Slepon, R., Robin, G., Hoke, C., Bankroft, W., Safary, A., Danon, Y., Winer, M.: Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J. Infect. Dis. 168 (1993) 740–743.
Troisi, C. L., Hollinger, F. B., Krause, D. S., Pickering, L. K.: Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®, SKB): a comparative study of two dosing schedules. Vaccine 15 (1997) 1613–1617.
Shapiro, C. N., Letson, G. W., Kuehn, D., Welty, T., Krause, D., Lanbert, S., Margolis, H. S.: Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. 35th Interscience Conference on antimicrobial Agents and Chemotherapy, San Francisco, 1995, abstr. H61.
Linder, N., Karetnyi, Y., Gidony, Y., Ohel, G., Levin, E., Kuint, J., Davidovich, N., Gidony, I., Mendelson, E., Barzilai, A.: Placental transfer of hepatitis A antibodies in full term and preterm infants. Pediatr. Infect. Dis. J. 16 (1997) 245–246.
Duermeyer, W. H., Wielaard, F., Van Der Veen, J.: A new principle for the detection of specific antibodies applied in an ELISA for hepatitis A. J. Med. Virol. 4 (1979) 25–32.
Duermeyer, W. H., Van Der Veen, J., Koster, B.: ELISA in hepatitis A. Lancet i (1978) 823–824.
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly. Rep. (1996 Dec. 27) 45 (RR 15) 1–30.
BMDP Statistical Software: Dixon, W. J. (ed.). University of California Press, Berkeley 1990.
Karetnyi, Y. V., Kuzin, S. N., Sychev, A. V., Balayan, M. S.: Transplacental antibodies to hepatitis A virus. [in Russian] Voprosy Virusologii 1 (1988) 86–88.
Ruiz-Gomez, J., Bustamante-Calivillo, M. E.: Hepatitis A antibodies: prevalence and persistence in a group of Mexican children. Am. J. Epidemiol. 121 (1985) 116–119.
Willcox, M. C., Andersson, C., Olsson, I.: The postnatal decline in antibody to hepatitis A virus. Trans. R. Soc. Trop. Med. Hyg. 79 (1985) 738.
Burek, V., Bace, A., Kacic, M., Belosevic, D., Mravunac, B.: Prevalence of antibodies to hepatitis A virus among urban children aged 0–7 years in Yugoslavia. Infection 10 (1985) 71–75.
Frösner, G. G., Papaevangelou, G., Butler, S., Iwarson, A., Lindholm, A., Courouce-Pauty, H., Deinhardt, F.: Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am. J. Epidemiol. 110 (1979) 63–69.
Maynard, J. E., Bradley, D. W., Hornbeck, C. L.: Preliminary serologic studies of antibody to hepatitis A virus in populations in the United States. J. Infect. Dis. 134 (1976) 528–530.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Linder, N., Karetnyi, Y., Gidony, Y. et al. Decline of hepatitis a antibodies during the first 7 months of life in full-term and preterm infants. Infection 27, 128–131 (1999). https://doi.org/10.1007/BF02560513
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02560513